Skip to content
Research Article Open access CC BY 4.0

Advancing Computer-Aided Drug Discovery (ACADD): In-Silico Approach towards Nuclear Receptors by Big Data

K. Palaniammal, M. Saravana Roentgen Mani, R. Mohan Kumar

Journal of Pharmaceutical Research International · pp. 40–46 · Published 29 May 2021

10.9734/jpri/2021/v33i30A31612

Abstract

The progression of drug discovery and development is time consuming and costly. Advancing Computer-aided drug discovery (ACADD) is an effective tool in reducing the time and cost of research and development. This study deals with the evaluation of the nuclear receptors for the in-silico biological activity using ligand betulinic acid and dexamethasone. Docking results showed that binding energy was -74.190 kcal/mol when compared with that of the standard (-51.551 kcal/mol). Interaction energy -44.16 & -25.14 kcal/mol) of the ligands also coincide with the binding energy. These ligands have shown the best ligand-receptor interaction based on their structural parameters.

Drug discovery docking in-silico betulinic acid ligands binding energy

Cited by 2

Review of bioinformatic tools used in Computer Aided Drug Design (CADD)

K. Namitha, V. Velmurugan · World Journal of Advanced Research and Reviews · 2022

Topic Modelling Using Latent Dirichlet Allocation Model for Pandemic Covid-19 Twitters Dataset

K. Sundravadivelu, K. Palaniammal, M. Saravana Roentgen Mani · Lecture Notes in Networks and Systems · 2025

Article metrics

Real usage data collected on this platform.

12

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.